Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877784 · ClinicalTrials.gov registry record
Screening in Oculopharyngeal Muscular Dystrophy
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 8
- Enrollment target
NCT02877784: Completed study, sponsored by University of Florida.
NCT02877784 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877784 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathic disease that results in progressive degeneration of the oral and pharyngeal muscular, resulting in severe dysphagia and dysarthria. OPMD is considered a rare disease; therefore, limited research is available on the natural progression of the disease or the utility of biomarkers to identify swallowing impairment. The aim of this study is: 1. To identify accurate, reliable and non-invasive clinical markers of swallowing impairment 2. To determine the discriminate ability of these markers to identify impairments in swallow safety and swallowing efficiency.
Primary Outcome
Global Metric of swallowing Safety and Efficiency
Interventions
- PROCEDURE Videofluoroscopic swallowing study
- OTHER Functional Oral Intake Scale
- OTHER Eating Assessment Tool-10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-08 |
What the finished NCT02877784 record still lists
NCT02877784 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Videofluoroscopic swallowing study is the first listed.
NCT02877784 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02877784 about?
NCT02877784 is a clinical study titled "Screening in Oculopharyngeal Muscular Dystrophy". Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathic disease that results in progressive degeneration of the oral and pharyngeal muscular, resulting in severe dysphagia and dysarthria. OPMD is considered a rare disease; therefore, limited research is available on the natural progression of ...
What is the current status of trial NCT02877784?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-10. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02877784?
The interventions under investigation include: Videofluoroscopic swallowing study (PROCEDURE), Functional Oral Intake Scale (OTHER), Eating Assessment Tool-10 (OTHER).
Who is sponsoring clinical trial NCT02877784?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia